Viewing Study NCT00778232


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2025-12-25 @ 7:26 PM
Study NCT ID: NCT00778232
Status: COMPLETED
Last Update Posted: 2008-10-23
First Post: 2008-10-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions
Sponsor: Ranbaxy Laboratories Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module